Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Tesamorelin stimulates physiologic release of endogenous growth hormone
The escalation schedule exists for a reason, and skipping doses creates unnecessary gastrointestinal distress without improving outcomes
Apikos Pharma ensures WHO-GMP compliance and advanced sterile manufacturing practices
Common Side Effects (Both Oral and Injectable): Gastrointestinal Issues: These are the most common side effects for all GLP-1 medications: Nausea: Oral semaglutide (Rybelsus): 11-20% of patients Injectable semaglutide (Wegovy): 44% of patients Injectable tirzepatide (Zepbound): 30-37% of patients Why the difference: Lower bioavailability of oral medication means less systemic exposure, potentially resulting in fewer GI side effects
This makes it a more affordable option for people who need help with weight management but cannot afford higher-cost treatments
US$ 28.33
US$ 24.67
US$ 22.73
US$ 26.83
US$ 28.08
US$ 25.19
